{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:30:08Z","timestamp":1761172208820,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.semerg.2023.102157","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T12:54:17Z","timestamp":1703768057000},"page":"102157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["El efecto del tratamiento de hierro en pacientes con insuficiencia cardiaca e insuficiencia de hierro. Un metaan\u00e1lisis de ensayos aleatorizados"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7325-7796","authenticated-orcid":false,"given":"H.","family":"Mej\u00eda-Zambrano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2023.102157_bib0155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s12012-021-09678-7","article-title":"Clinical Value of Circulating ZFAS1 and miR-590-3p in the Diagnosis and Prognosis of Chronic Heart Failure","volume":"21","author":"Chang","year":"2021","journal-title":"Cardiovasc Toxicol."},{"key":"10.1016\/j.semerg.2023.102157_bib0160","doi-asserted-by":"crossref","first-page":"112517","DOI":"10.1016\/j.ecoenv.2021.112517","article-title":"Association between long-term exposure to ambient air pollution and clinical outcomes among patients with heart failure: Findings from the China PEACE Prospective Heart Failure Study","volume":"222","author":"Shi","year":"2021","journal-title":"Ecotoxicol Environ Saf."},{"key":"10.1016\/j.semerg.2023.102157_bib0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J."},{"key":"10.1016\/j.semerg.2023.102157_bib0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmjebm-2019-111198","article-title":"\u00bfSe debe descartar el hierro oral en pacientes con insuficiencia cardiaca?","volume":"25","author":"De Las Nieves","year":"2020","journal-title":"Medicina basada en BMJ Evid."},{"key":"10.1016\/j.semerg.2023.102157_bib0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.35839\/repis.6.2.1131","article-title":"Inhibidores del SGTL-2 en pacientes con insuficiencia cardiaca y fracci\u00f3n de eyecci\u00f3n reducida con o sin diabetes: revisi\u00f3n sist\u00e9mica","volume":"6","author":"Mej\u00eda-Zambrano","year":"2022","journal-title":"Rev Peru Investig Salud [Internet]."},{"key":"10.1016\/j.semerg.2023.102157_bib0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCULATIONAHA.121.054271","article-title":"Intravenous Iron Therapy in Heart Failure With Reduced Ejection Fraction: Tackling the Deficiency","volume":"144","author":"Sawicki","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2023.102157_bib0185","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ejhf.473","article-title":"Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials","volume":"18","author":"Jankowska","year":"2016","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.semerg.2023.102157_bib0190","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.semerg.2023.102157_bib0195","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2015.05.006","article-title":"Repletion of Iron Stores With the Use of Oral Iron Supplementation in Patients With Systolic Heart Failure","volume":"21","author":"Niehaus","year":"2015","journal-title":"J Card Fail."},{"key":"10.1016\/j.semerg.2023.102157_bib0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semerg.2022.01.004","article-title":"Seguridad y efectividad de la dapagliflozina con otro inhibidor del SGLT-2: \u00bfqu\u00e9 decisi\u00f3n tomar?","volume":"48","author":"Mej\u00eda-Zambrano","year":"2022","journal-title":"Semergen."},{"key":"10.1016\/j.semerg.2023.102157_bib0205","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s11886-023-01889-4","article-title":"Treatment of Iron Deficiency in Heart Failure","volume":"25","author":"Shamsi","year":"2023","journal-title":"Curr Cardiol Rep."},{"key":"10.1016\/j.semerg.2023.102157_bib0210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00277-020-04338-2","article-title":"Correction of iron deficiency in hospitalized heart failure patients does not improve patient outcomes","volume":"100","author":"Mistry","year":"2021","journal-title":"Ann Hematol."},{"key":"10.1016\/j.semerg.2023.102157_bib0215","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13539-014-0155-9","article-title":"Ventricular assist device implantation improves skeletal muscle function, oxidative capacity, and growth hormone\/insulin-like growth factor-1 axis signaling in patients with advanced heart failure","volume":"5","author":"Khawaja","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"10.1016\/j.semerg.2023.102157_bib0220","first-page":"e4408","article-title":"Efectos de los agonistas del receptor de p\u00e9ptido similar al glucag\u00f3n tipo 1 como tratamiento en pacientes con obesidad y diabetes mellitus tipo 2","volume":"21","author":"Mej\u00eda-Zambrano","year":"2022","journal-title":"Rev habanera cienc m\u00e9d."},{"key":"10.1016\/j.semerg.2023.102157_bib0225","doi-asserted-by":"crossref","first-page":"472","DOI":"10.35434\/rcmhnaaa.2022.153.1511","article-title":"El s\u00edndrome inadecuado de la hormona antidiur\u00e9tica como una causa de hiponatremia en pacientes con COVID-19 severo","volume":"15","author":"Mejia Zambrano","year":"2022","journal-title":"Rev Cuerpo Med. HNAAA [Internet]."},{"key":"10.1016\/j.semerg.2023.102157_bib0230","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000496822","article-title":"Management of Iron Deficiency in Heart Failure","volume":"142","author":"Zusman","year":"2019","journal-title":"Acta Haematol."},{"key":"10.1016\/j.semerg.2023.102157_bib0235","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/1049732312452938","article-title":"Beyond PICO: the SPIDER tool for qualitative evidence synthesis","volume":"22","author":"Cooke","year":"2012","journal-title":"Qual Health Res."},{"key":"10.1016\/j.semerg.2023.102157_bib0240","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2021.06.016","article-title":"Declaraci\u00f3n PRISMA 2020 una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol."},{"year":"2019","series-title":"Revised Cochrane risk-of-bias tool for randomized trials (RoB 2)","author":"Higgins","key":"10.1016\/j.semerg.2023.102157_bib0245"},{"key":"10.1016\/j.semerg.2023.102157_bib0250","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1161\/CIRCULATIONAHA.122.060511","article-title":"Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF","volume":"146","author":"Docherty","year":"2022","journal-title":"Circulation."},{"issue":"10369","key":"10.1016\/j.semerg.2023.102157_bib0255","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet."},{"issue":"10266","key":"10.1016\/j.semerg.2023.102157_bib0260","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.semerg.2023.102157_bib0265","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.amjcard.2021.04.042","article-title":"Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure","volume":"152","author":"Ambrosy","year":"2021","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.semerg.2023.102157_bib0270","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.semerg.2023.102157_bib0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5334\/gh.1151","article-title":"Oral Ferrous Sulphate Improves Functional Capacity on Heart Failure Patients with Iron Deficiency Anemia","volume":"17","author":"Suryani","year":"2022","journal-title":"Glob Heart."},{"key":"10.1016\/j.semerg.2023.102157_bib0280","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.122.060757","article-title":"Association Between Hemoglobin Levels and Efficacy of Intravenous Ferric Carboxymaltose in Patients With Acute Heart Failure and Iron Deficiency: An AFFIRM-AHF Subgroup Analysis","volume":"147","author":"Filippatos","year":"2023","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2023.102157_bib0285","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation."},{"key":"10.1016\/j.semerg.2023.102157_bib0290","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.3390\/nu14235057","article-title":"Effect of Ferric Carboxymaltose Supplementation in Patients with Heart Failure with Preserved Ejection Fraction: Role of Attenuated Oxidative Stress and Improved Endothelial Function","volume":"14","author":"Mollace","year":"2022","journal-title":"Nutrients."},{"key":"10.1016\/j.semerg.2023.102157_bib0295","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.3390\/nu5093730","article-title":"Iron Deficiency in Heart Failure: A Practical Guide","volume":"5","author":"Ebner","year":"2013","journal-title":"Nutrients."},{"key":"10.1016\/j.semerg.2023.102157_bib0300","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J Am Coll Cardiol."}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113835932300237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S113835932300237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:43:19Z","timestamp":1761108199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S113835932300237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S113835932300237X"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2023.102157","relation":{},"ISSN":["1138-3593"],"issn-type":[{"type":"print","value":"1138-3593"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"El efecto del tratamiento de hierro en pacientes con insuficiencia cardiaca e insuficiencia de hierro. Un metaan\u00e1lisis de ensayos aleatorizados","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2023.102157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102157"}}